See also: Generic Omnipaque 140, Generic Omnipaque 180, Generic Omnipaque 240, Generic Omnipaque 350
Omnipaque 300 is a brand name of iohexol, approved by the FDA in the following formulation(s):
OMNIPAQUE 300 (iohexol - solution; injection, oral, rectal)
Manufacturer: GE HEALTHCARE
Approval date: December 26, 1985
Strength(s): 64.7% [RLD]
Manufacturer: GE HEALTHCARE
Approval date: October 24, 1995
Strength(s): 64.7%
Has a generic version of Omnipaque 300 been approved?
No. There is currently no therapeutically equivalent version of Omnipaque 300 available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Omnipaque 300. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Omnipaque 300.
No comments:
Post a Comment